Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYPNOTIC Pilot Study
NCT06109961Phase 2Not yet recruiting
- Sponsor
- University of British Columbia
- Start
- Sep 2026
- Primary completion
- Sep 2027
- Modality
- Inhalation Devices
01
Overview
A Phase 2 trial of oxygen in Crohn's disease, sponsored by University of British Columbia. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
oxygen
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT06109961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06109961.